Pharmaceutical agents for the inhibition of angiogenesis

Details Pharmaceutical agents for the inhibition of angiogenesis Pharmaceutical agents for the inhibition of angiogenesis

A - Human Necessities

61

K

A61K 31/33 (2006.01) A61K 31/135 (2006.01) A61K 31/40 (2006.01) A61K 31/435 (2006.01) A61K 31/445 (2006.01) A61K 31/55 (2006.01)

Patent

CA 2136295

The present invention relates to medicine for (a) inhibiting angiogenesis in mammal or (b) treating or preventing a disease or condition that is caused or mediated by angiogenesis or of which angiogenesis is a symptom in a mammal, using compounds that are substance P receptor antagonists and, specifically, certain quinuclidine derivatives, piperidine derivatives, pyrrolidine derivatives, azanorbornane derivatives, ethylene diamine derivatives and related compounds.

Affiliated with

Also associated with

Rating

Pharmaceutical agents for the inhibition of angiogenesis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical agents for the inhibition of angiogenesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical agents for the inhibition of angiogenesis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1803890